Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes—Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial
Bart L. Scott, Marcelo C. Pasquini, Mingwei Fei, Raphael Fraser, Juan Wu, Steve Devine, David L. Porter, Richard T. Maziarz, Erica D. Warlick, Hugo F. Fernández, Robert J. Soiffer, Edwin P. Alyea, Mehdi Hamadani, Asad Bashey, Sergio Giralt, Nancy L. Geller, Eric Leifer, Christopher S. Hourigan, Gege Gui, Adam Mendizabal, Mary M. Horowitz, H. Joachim Deeg, Mitchell E. Horwitz
Topics & Concepts
MedicineHazard ratioInternal medicineTransplantationRandomized controlled trialMyelodysplastic syndromesClinical endpointHematopoietic stem cell transplantationLeukemiaOncologySurgeryGastroenterologyBone marrowConfidence intervalAcute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia research